The initiative of theBiosimilar Month” Its objective is to disseminate the added value that biosimilar medicines have for health systems through a series of activities related to training and information for health professionals, administration, patients and citizens in general. Health professionals, patient associations, scientific societies, professional associations, the pharmaceutical industry and health administration have collaborated in it, our gratitude is directed to all of them for their disinterested and proactive collaboration.
Throughout this month of November we will try to disseminate and share information that allows a better knowledge of the added value that biosimilar medicines bring to health systems; a value that goes beyond the important contribution to the sustainability of the National Health System and that allows more patients to access biological drugs of quality, safety and proven health results.
The initiative also incorporates actions that will be coordinated with international proposals such as the Global Biosimilar Week and the European Biosimilar Week that will be held from November 16 to 20, 2020.
We trust that the activities that take place throughout this month will be of the greatest interest and we encourage you to join them with the hashtag “#mesdelbiosimilar”.
Encarnación Cruz Martos
General Director of BioSim
